NCT02386254 (ECOG) is a clinical trial in ICU Mortality, sponsored by University of Oklahoma.

Who is sponsoring NCT02386254?

NCT02386254 is sponsored by University of Oklahoma.

What condition does NCT02386254 study?

NCT02386254 studies ICU Mortality, ICU Morbidity.

Is NCT02386254 still recruiting?

NCT02386254 is currently withdrawn. Last updated 12 March 2024.

Last reviewed 2024-03-12 · How we verify

NCT02386254: ECOG

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adaptation of a Premorbid Function Scoring System as a Predictor for Intensive Care Unit Mortality

Withdrawn Last updated 12 March 2024

What this trial tests

trial in ICU Mortality. Withdrawn.

Timeline

26 November 2018

Primary endpoint
18 November 2019

18 November 2019

Quick facts

Lead sponsor	University of Oklahoma
Status	Withdrawn
Study type	OBSERVATIONAL
Start date	26 November 2018
Primary completion	18 November 2019
Estimated completion	18 November 2019
Sites	1 location across United States

Conditions studied

ICU Mortality — all drugs for ICU Mortality →
ICU Morbidity — all drugs for ICU Morbidity →

Sponsor

University of Oklahoma

Who can join

18 and older, any sex, with ICU Mortality or ICU Morbidity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate whether a premorbid functioning scoring system such as the ECOG system can be adapted to predict ICU morbidity and mortality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Oklahoma trials

Trials by the same sponsor.

NCT07219706 — Dietary Fiber and Time Restricted Eating · NA · recruiting
NCT07494773 — Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection · Phase 1, PHASE2 · not yet recruiting
NCT07014605 — Smoking Cessation Program for Lao People With HIV · NA · not yet recruiting
NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07491653 — Fiber mHealth Intervention for Prediabetes · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02386254 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Oklahoma
Last refreshed: 12 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02386254.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing